Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kasper

Showing results (351-360 of 497) with videos related to

Pageof 50
Sort By:
Addiction (Abingdon, England)|January 1, 2000
Buprenorphine versus methadone maintenance for the treatment of opioid dependenceG Fischer, W Gombas, H Eder, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 20, 2021
Changes in fatigue, barriers, and predictors towards physical activity in advanced cancer patients over a period of 12 months-a comparative studyJ Frikkel, M Beckmann, N De Lazzari, et al.
Biology of Reproduction|November 25, 2000
Characterization of an androgen-specific response region within the 5' flanking region of the murine epididymal retinoic acid binding protein geneJ J Lareyre, K Reid, C Nelson, et al.
Brain : a Journal of Neurology|September 7, 2010
Neuropathology of epilepsy and psychosis: the contributions of J.A.N. CorsellisBurkhard S Kasper, David C Taylor, Dieter Janz, et al.
The Prostate|August 27, 1998
Differential transactivation by the androgen receptor in prostate cancer cellsR Snoek, N Bruchovsky, S Kasper, et al.
Psychiatric Genetics|February 24, 2001
Non-association of dopamine D4 and D2 receptor genes with personality in healthy individualsC Gebhardt, F Leisch, P Schüssler, et al.
Psychopharmacology|February 10, 1999
In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidolJ Tauscher, B Küfferle, S Asenbaum, et al.
Psychiatry Research|December 16, 1998
Cerebral CT findings in male opioid-dependent patients: stereological, planimetric and linear measurementsL M Pezawas, G Fischer, K Diamant, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administrationM Bagli, R Süverkrüp, R Quadflieg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 1, 2004
ECNP Consensus Meeting, March 2003. Guidelines for the investigation of efficacy in social anxiety disorderS A Montgomery, Y Lecrubier, D S Baldwin, et al.
Pageof 50

Showing results (351-360 of 497) with videos related to

Sort By:
Pageof 50
Addiction (Abingdon, England)|January 1, 2000
Buprenorphine versus methadone maintenance for the treatment of opioid dependenceG Fischer, W Gombas, H Eder, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 20, 2021
Changes in fatigue, barriers, and predictors towards physical activity in advanced cancer patients over a period of 12 months-a comparative studyJ Frikkel, M Beckmann, N De Lazzari, et al.
Biology of Reproduction|November 25, 2000
Characterization of an androgen-specific response region within the 5' flanking region of the murine epididymal retinoic acid binding protein geneJ J Lareyre, K Reid, C Nelson, et al.
Brain : a Journal of Neurology|September 7, 2010
Neuropathology of epilepsy and psychosis: the contributions of J.A.N. CorsellisBurkhard S Kasper, David C Taylor, Dieter Janz, et al.
The Prostate|August 27, 1998
Differential transactivation by the androgen receptor in prostate cancer cellsR Snoek, N Bruchovsky, S Kasper, et al.
Psychiatric Genetics|February 24, 2001
Non-association of dopamine D4 and D2 receptor genes with personality in healthy individualsC Gebhardt, F Leisch, P Schüssler, et al.
Psychopharmacology|February 10, 1999
In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidolJ Tauscher, B Küfferle, S Asenbaum, et al.
Psychiatry Research|December 16, 1998
Cerebral CT findings in male opioid-dependent patients: stereological, planimetric and linear measurementsL M Pezawas, G Fischer, K Diamant, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administrationM Bagli, R Süverkrüp, R Quadflieg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 1, 2004
ECNP Consensus Meeting, March 2003. Guidelines for the investigation of efficacy in social anxiety disorderS A Montgomery, Y Lecrubier, D S Baldwin, et al.
Pageof 50